BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33845044)

  • 1. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
    Sambasivan K; Sassoon I; Thavaraj S; Kennedy R; Doss G; Michaelidou A; Odell E; Sandison A; Hall G; Morgan P; Collins LHC; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Petkar I; Reis Ferreira M; Kong A; Lei M; Guerrero Urbano T
    Radiother Oncol; 2021 Jul; 160():54-60. PubMed ID: 33845044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
    Holcomb AJ; Farrokhian N; Tolan C; Whiteford E; Villwock M; Kakarala K; Shnayder Y; Sykes K; Lominska C; Gan G; Buchakjian MR; Harding B; Dooley L; Shinn J; Burton Wood C; Rohde S; Khaja S; Abt NB; Varvares M; Bur AM
    Oral Oncol; 2023 Jul; 142():106420. PubMed ID: 37182430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
    De Felice F; Bird T; Michaelidou A; Thavaraj S; Odell E; Sandison A; Hall G; Morgan P; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Lei M; Guerrero Urbano T
    Radiother Oncol; 2020 Apr; 145():146-153. PubMed ID: 31981964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.
    Tagliabue M; De Berardinis R; Belloni P; Gandini S; Scaglione D; Maffini F; Mirabella RA; Riccio S; Gioacchino G; Bruschini R; Chu F; Ansarin M
    Acta Otorhinolaryngol Ital; 2022 Apr; 42(2):140-149. PubMed ID: 35612505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction.
    Hafström A; Wahlberg P; Klasson S; Greiff L; Sjövall J
    Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2953-2964. PubMed ID: 36897366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depth of invasion alone as a prognostic factor in low-risk early-stage oral cavity carcinoma.
    Kozak MM; Shah J; Chen M; Schaberg K; von Eyben R; Chen JJ; Bui T; Kong C; Kaplan M; Divi V; Hara W
    Laryngoscope; 2019 Sep; 129(9):2082-2086. PubMed ID: 30604435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes for recurrent oral cavity squamous cell carcinoma.
    Contrera KJ; Zafereo ME; Yaniv D; Roberts DB; Gillenwater AM; Hanna EY; Weber RS; Myers JN; Chang EI; Garvey PB; Hanasono MM; Yu P; Hutcheson KA; Fuller CD; Tyler MA; Neskey DM
    Oral Oncol; 2022 Nov; 134():106127. PubMed ID: 36155359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of postoperative radiotherapy in intermediate-risk oral squamous cell carcinoma.
    Liu T; David M; Batstone M; Clark J; Low TH; Goldstein D; Hope A; Hosni A; Chua B
    Int J Oral Maxillofac Surg; 2021 Feb; 50(2):143-150. PubMed ID: 32616305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study.
    Zittel S; Moratin J; Horn D; Metzger K; Ristow O; Engel M; Mrosek J; Freier K; Hoffmann J; Freudlsperger C
    Clin Oral Investig; 2022 Feb; 26(2):2055-2064. PubMed ID: 34581884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with disease recurrence in patients with T4 staged Squamous Cell Carcinoma of the Oral Cavity treated with surgery and postoperative radiotherapy.
    Hassan NH; Ayub B; Qureshi TA; Shaikh SA; Kazi M; Usman R; Haroon US
    J Pak Med Assoc; 2022 Dec; 72(12):2399-2403. PubMed ID: 37246656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
    Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adjuvant radiotherapy in locally advanced T4 mandible squamous cell carcinoma in the N0 patient: a single centre experience.
    Lee CW; Jenkins GW; Lee-Warder L; Kennedy M; Iqbal MS; Adams J
    Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1251-1256. PubMed ID: 35090786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.
    Tam S; Araslanova R; Low TH; Warner A; Yoo J; Fung K; MacNeil SD; Palma DA; Nichols AC
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):685-690. PubMed ID: 28448645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic performance of TNM8 staging rules in oral cavity squamous cell carcinoma.
    Jawad H; Ashaari SS; O'Shea R; Callanan D; Sheahan P; Feeley L
    Oral Oncol; 2020 Dec; 111():105021. PubMed ID: 33011675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.